GI Malignancies Debate 2022

GI Malignancies Debate 2022: November
16–18 November 2022 | Virtual Meeting
The 2022 Great Debates and Updates Series are multi-day, debate-driven conferences focusing on the treatment of gastrointestinal malignancies. Attendees can expect a comprehensive overview of scientific advances in Colorectal Cancers, Hepatobiliary Cancers, Immuno-Oncology, Pancreatic Cancers, and much more.

GI Malignancies Debate 2022

GI Malignancies Debate 2022: November
16–18 November 2022 | Virtual Meeting
The 2022 Great Debates and Updates Series are multi-day, debate-driven conferences focusing on the treatment of gastrointestinal malignancies. Attendees can expect a comprehensive overview of scientific advances in Colorectal Cancers, Hepatobiliary Cancers, Immuno-Oncology, Pancreatic Cancers, and much more.
Surgical advances in in gastric and GEJ cancer 5:00
Surgical advances in in gastric and GEJ cancer
Deepa Magge • 2 Dec 2022
The role of HIPEC in peritoneal mesothelioma, GI and ovarian cancers 1:10
The role of HIPEC in peritoneal mesothelioma, GI and ovarian cancers
Deepa Magge • 2 Dec 2022
Highlights from the 2022 Great Debates & Updates in GI Malignancies Congress 1:31
Highlights from the 2022 Great Debates & Updates in GI Malignancies Congress
Nitya Raj • 21 Nov 2022
Unmet needs in the management of neuroendocrine tumors 2:41
Unmet needs in the management of neuroendocrine tumors
Nitya Raj • 21 Nov 2022
Treatment options for appendix cancer 4:44
Treatment options for appendix cancer
Deepa Magge • 2 Dec 2022
Assessing the benefits of HIPEC in GI cancers 2:46
Assessing the benefits of HIPEC in GI cancers
Deepa Magge • 2 Dec 2022
Checkpoint inhibition in hepatocellular carcinoma 4:53
Checkpoint inhibition in hepatocellular carcinoma
Ghassan Abou-Alfa • 23 Nov 2022
The emerging role of immunotherapy in cholangiocarcinoma 5:56
The emerging role of immunotherapy in cholangiocarcinoma
Ghassan Abou-Alfa • 23 Nov 2022
177Lu-DOTATATE in patients with well-differentiated, high-grade NETs 1:57
177Lu-DOTATATE in patients with well-differentiated, high-grade NETs
Nitya Raj • 21 Nov 2022
Novel approaches in treating gastrointestinal neuroendocrine tumors 1:17
Novel approaches in treating gastrointestinal neuroendocrine tumors
Nitya Raj • 21 Nov 2022
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals